Last $100.22 USD
Change Today +0.04 / 0.04%
Volume 5.9M
As of 6:40 PM 04/23/14 All times are local (Market data is delayed by at least 15 minutes).

johnson & johnson (JNJ) Snapshot

Open
$100.24
Previous Close
$100.18
Day High
$100.56
Day Low
$99.92
52 Week High
04/22/14 - $100.75
52 Week Low
06/20/13 - $82.12
Market Cap
283.5B
Average Volume 10 Days
9.5M
EPS TTM
$5.64
Shares Outstanding
2.8B
EX-Date
02/21/14
P/E TM
17.8x
Dividend
$2.64
Dividend Yield
2.63%
Current Stock Chart for JOHNSON & JOHNSON (JNJ)

johnson & johnson (JNJ) Details

Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers a range of products used in the baby care, skin care, oral care, wound care, and women’s health fields, as well as nutritionals, over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON’S, AVEENO, CLEAN & CLEAR, DABAO, JOHNSON’S Adult, LUBRIDERM, NEUTROGENA, RoC, VENDÔME, LISTERINE, BAND-AID, NEOSPORIN, STAYFREE, CAREFREE, o.b. tampon, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, cardiovascular, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, metabolic, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers various products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products to wholesalers, hospitals, and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.

128,300 Employees
Last Reported Date: 04/15/14
Founded in 1885

johnson & johnson (JNJ) Top Compensated Officers

Chairman, Chief Executive Officer, Chairman o...
Total Annual Compensation: $1.5M
Chief Financial Officer, Vice President of Fi...
Total Annual Compensation: $842.3K
Group Worldwide Chairman and Member of Execut...
Total Annual Compensation: $2.7M
Chief Scientific Officer, Worldwide Chairman ...
Total Annual Compensation: $952.9K
Vice President, General Counsel and Member of...
Total Annual Compensation: $542.3K
Compensation as of Fiscal Year 2013.

johnson & johnson (JNJ) Key Developments

Johnson & Johnson Signs Agreement with USO to Healthcare Partner

Johnson & Johnson, has entered into a multi-year agreement to be the healthcare partner of the USO.

Johnson & Johnson Announces Unaudited Consolidated Earnings Results for First Quarter of 2014

Johnson & Johnson announced unaudited consolidated earnings results for first quarter of 2014. For the quarter, the company reported sales to customers of $18,115 million, earnings before provision for taxes on income of $5,424 million, net earnings of $4,727 million or $1.64 per diluted share compared to the sales to customers of $17,505 million, earnings before provision for taxes on income of $4,261 million, net earnings of $3,497 million or $1.22 per diluted share for the same quarter a year ago.

Johnson & Johnson Provides EPS Guidance for the Year 2014

Johnson & Johnson provided EPS guidance for the year 2014. For the full year, the company increased its EPS view to a range of $5.80 to $5.90.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JNJ:US $100.22 USD +0.04

JNJ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Merck & Co Inc $57.50 USD -0.27
Novartis AG SFr.76.25 CHF -0.15
Pfizer Inc $30.92 USD -0.08
Roche Holding AG SFr.256.20 CHF -0.60
Procter & Gamble Co/The $80.36 USD -0.89
View Industry Companies
 

Industry Analysis

JNJ

Industry Average

Valuation JNJ Industry Range
Price/Earnings 19.2x
Price/Sales 4.0x
Price/Book 3.8x
Price/Cash Flow 18.8x
TEV/Sales 3.3x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JOHNSON & JOHNSON, please visit www.jnj.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.